Abstract
High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry dataset for each HDR source model. The main objective of the present work is to measure 2D relative dose distribution around a new prototype 192Ir source, referred to as IRAsource‐HDR, in PMMA phantom in the framework of AAPM TG‐43 and TG‐55 recommendations for radial distances of 0.5 cm to 4 cm. Radiochromic films (RCFs) Gafchromic EBT and HD‐810 were used for measurements. The dose rate constant, Λ, of the source was determined to be 1.084±4.6%,1.129±4.4%, and 1.112±0.8% cGyh−1U−1 using EBTRCF, HD‐810 RCF, and Monte Carlo (MC) simulation, respectively. The results obtained in this study are in good agreement with previously published data for HDR interstitial 192Ir‐HDR sources with a maximum discrepancy of ±4.5%. An acceptable agreement (within ±2%) between MC calculations and RCFs measurements showed that HD‐810 RCF dosimetry is as good as EBTRCF, within HDR brachytherapy, and justifies the use of specific data for this new source. These data could be used as a benchmark for dose calculations in the conventional brachytherapy treatment planning systems.PACS number(s): 87.56.bg
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
